Showing results (71-80 of 194) with videos related to
Sort By:
Pageof 20
World Journal of Clinical Cases|July 5, 2021
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts resultsXavier Adhoute, Edouard Larrey, Rodolphe Anty, et al.Journal of Hepatology|December 3, 2014
Retreatment with TACE: the ABCR SCORE, an aid to the decision-making processXavier Adhoute, Guillaume Penaranda, Sebastien Naude, et al.Hepatology (Baltimore, Md.)|January 30, 2016
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)Vincent Leroy, Peter Angus, Jean-Pierre Bronowicki, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION TrialsJason Grebely, Stefan Mauss, Ashley Brown, et al.European Journal of Gastroenterology & Hepatology|October 19, 2004
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosisArmand Abergel, Claude Darcha, Michèle Chevallier, et al.Journal of Hepatology|January 29, 2008
Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West AfricaJean-Pierre Bronowicki, Idrissia Abdelmouttaleb, Laurent Peyrin-Biroulet, et al.European Journal of Gastroenterology & Hepatology|May 3, 2019
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.Antimicrobial Agents and Chemotherapy|July 17, 2013
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis CDominique Larrey, Ansgar W Lohse, Christian Trepo, et al.Plos One|October 20, 2012
Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapyStella M Martinez, Juliette Foucher, Jean-Marc Combis, et al.European Journal of Gastroenterology & Hepatology|December 24, 2015
Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter studyXavier Adhoute, Guillaume Pénaranda, Jean L Raoul, et al.Pageof 20